Ondansetron ODT 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FXE16
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,183
Award facts
- Contract value 100% obligated
- $13,183.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Ondansetron ODT 4 mg tablets in a 30-count package. This competitively awarded, non-set-aside contract carries a ceiling value of $13,183.27 and utilizes firm fixed price terms, with an ultimate completion date of September 5, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capability to deliver a comprehensive range of pharmaceutical products across multiple therapeutic domains on a competitively awarded basis. This Ondansetron supply order supports DLA's medical supply chain operations, which serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems requiring antiemetic medications for clinical use.
Quick answers
Who was awarded contract SPE2DB25FXE16?
SPE2DB25FXE16 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FXE16 worth?
The government has obligated $13,183 on SPE2DB25FXE16.
Is contract SPE2DB25FXE16 an order under another contract?
Yes. SPE2DB25FXE16 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FXE16 competed?
The extent of competition for SPE2DB25FXE16 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award